Rivercell Launches With $25 Million to Build Data Platforms and AI Models That Predict How Human Cells Respond to Treatment
7.10.2026 15:00:00 CEST | Business Wire | Press Release
Rivercell, a Paris-based biotechnology and AI company building its own data infrastructure on how human cells respond to any treatment and training a world model of the cell that can predict those responses, today announced a $25 million seed round led by HV. HCVC, Alven and Bpifrance Digital Venture also participated in the round, which will fund the scale-up of Rivercell’s proprietary data generation platform, the expansion of its wet lab in Paris (a lab working with chemicals and biological samples), and the launch of its AI Virtual Cell program. Being indication-agnostic, Rivercell's world model can drive groundbreaking discovery across any cell behavior that leads to disease because it learns the underlying rules of how human cells respond to drugs and genetic changes, not the features of a single disease.
Rivercell was started in summer 2025 by CEO Yann Fleureau, the engineer-turned-entrepreneur behind AI company Cardiologs, joined in 2026 by CSO Eric Durand, an AI scientist and former C-Level executive at AI drug discovery unicorn Owkin. Rivercell builds a proprietary platform that generates massive, high-quality pre-training datasets to train its “AI virtual cell” (AIVC) model. AIVC is a world model designed to predict how human cells respond to a drug or genetic change in silico, reducing the overall need for physical wet-lab experiments significantly. Rivercell’s long-term goal is to fundamentally change drug discovery by accelerating and redesigning it. Developing a single drug can take years and be costly, with the industry investing nearly $300 billion in R&D each year.
Realizing this potential depends on data. AlphaFold revolutionized protein structure prediction because it could draw on decades of publicly available protein structure data. Building a comparable model of the cell is a far greater challenge: it requires diverse, multimodal, time-resolved data on how cells respond to perturbations. No such dataset exists at the scale needed today, so Rivercell is creating that foundation. The company generates a large-scale biological dataset and uses it to train its AI virtual cell. Because today's laboratory instruments were not designed for this application, Rivercell is developing an innovative, purpose-built platform capable of capturing the data at the scale required to pre-train its world model. The company describes this platform as the "GPU for the bio data center" of the future.
“A world model of the cell is the opportunity of the century in medicine. The missing piece is data: how cells change over time and under treatment, seen through multiple lenses and at multiple layers, captured at scale. Building that data engine in Europe is strategic, not only for Rivercell but for the continent's place in AI and biology," said Yann Fleureau, co-founder and CEO of Rivercell.
Engineer and serial entrepreneur Yann Fleureau previously co-founded and led AI diagnostics company Cardiologs, raising several funding rounds before its nine-figure acquisition by Philips in 2021. Data scientist Eric Durand was director of oncology data science at Novartis and served as Chief Data Science Officer at Owkin before co-founding bio foundation model company Bioptimus, which raised $76 million.
“AI is already rewriting how we understand the chemistry of life, from protein structure to molecular design. The next frontier is predicting how cells behave, and that requires a full-stack approach that combines a novel platform, automated wet labs, and world models. Yann and Eric bring exactly this combination of expertise, and with its footing in both Paris's AI ecosystem and Basel's pharma cluster, Rivercell is uniquely positioned to lead it,” said Maxi Pethö-Schramm, Principal at HV.
Rivercell is also backed by scientific advisors including Dr. Charlotte Bunne and Prof. Dr. Dr. Fabian Theis and angel investors including founders and executives from Twist Bioscience, DNA Script, Agilent and Abivax/Ipsen.
“AI virtual cells will transform how we understand and engineer biology. Rivercell’s ambition to unite large-scale perturbation experiments with AI simulation is why I’m excited to join its Scientific Advisory Board,” said Dr.Charlotte Bunne, Assistant Professor, Artificial Intelligence in Molecular Medicine at EPFL.
"Understanding how cells respond to perturbations, over time rather than in snapshots, is one of the big open problems in biology. Rivercell is tackling it at scale, with both the data and the AI models to match. I'm thrilled to join its Scientific Advisory Board," closed Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich, Scientific Director of Helmholtz AI and Professor of Mathematical Modeling of Biological Systems at the Technical University of Munich.
About Rivercell
Rivercell is building the data engine and the AI model that predict how living cells respond to drugs and genetic changes. Its proprietary in-house platform produces interventional, time-resolved, multimodal single-cell data at scale, which trains Rivercell's own AI world model of the cell. Rivercell is based in Paris, France. Learn more at rivercell.ai.
About its founders:
Yann Fleureau, a graduate of École Polytechnique and UC Berkeley, co-founded and led Cardiologs, the market leader in AI-based cardiac diagnostics, raising successive venture rounds before Philips acquired the company in 2021 in a nine-figure exit. Its technology now supports the diagnosis of more than two million patients a year. He also co-founded Numina, a non-profit developing AI for frontier reasoning in mathematics and physics.
Eric Durand, Rivercell’s co-founder and Chief Scientific Officer, spent seven years as Director of Data Science in oncology at Novartis, supporting hundreds of drug programs. He went on to serve as Chief Data Science Officer at Owkin, where he grew the AI team from 20 to more than 100 engineers, and co-founded the biology foundation-model company Bioptimus, which raised $76 million. Earlier in his career, he built one of the first consumer ancestry algorithms at 23andMe. He holds a PhD in statistics and population genetics and conducted postdoctoral studies at UC Berkeley.
About HV
HV is one of the leading early-stage and growth investors in Europe. With nine fund generations in 26 years and €2.8 bn in managed assets, HV is one of the continent's most active investors. The investment team has many years of experience in identifying European startups with great potential for success. In addition to international success stories like Flix, Zalando, Delivery Hero, Sumup, and Depop, innovation leaders such as Quantum Systems, Marvel Fusion, AMI Labs, Neura Robotics, Enpal, and Isar Aerospace, are also part of the portfolio. HV has invested in more than 290 internet and technology companies, supporting startups with ticket sizes ranging from €0.5m to €60m. It is one of Europe's few venture capital firms that can finance startups through all growth phases. HV has a team of more than 60+ investment and operations professionals who provide a variety of perspectives and expertise across the venture capital landscape.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261007283522/en/
Contacts
Rivercell Media contact:
press@rivercell.ai
HV Media contact:
Kekst CNC
hvcapital@kekstcnc.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Canada to Join the NATO Innovation Fund to Advance the Local Defence, Security and Resilience Ecosystem21.11.2026 17:00:00 CET | Press Release
Canada announced today it is joining the NATO Innovation Fund, becoming the 25th Allied nation to commit to backing deep tech innovation to address the needs of NATO nations. The Government of Canada is committing EUR 64,590,000 (approximately CAD $100 million) to the firm, with the Business Development Bank of Canada (BDC) holding and managing Canada’s investment in the Fund. This brings total commitments to the NATO Innovation Fund to more than EUR 1.1 billion. Canadian membership will give domestic innovators access to patient capital, opportunities to accelerate the adoption of their technology by governments and businesses across the Alliance, a large network of co-investors, and lessons learned from the NIF’s work to date across 24 participating nations. “Canada has the talent, the innovation, and the ambition to be a global leader in defence and security. The NATO Innovation Fund is helping turn that potential into real capabilities by connecting Canadian innovators with the inv
Persona Earns CEN/TS 18099 High Certification for Injection Attack Detection21.11.2026 15:30:00 CET | Press Release
Persona, the leading global identity platform, today announced that its Android SDK has earned CEN/TS 18099 High certification for injection attack detection (IAD). High certification is the top level of the European standard. The evaluation was run by CLR CERT, the certification body of Cabinet Louis Reynaud (CLR) Labs. CLR Labs is accredited under ISO/IEC 17025, the international standard for testing laboratories, and it edits CEN/TS 18099. This certificated injection attack detection is available to all Persona customers and can be activated by working with Persona's team. Injection attacks skip the camera entirely. Instead of holding a photo or mask up to a lens, fraudsters use virtual cameras, emulators and tampered devices to feed stolen, manipulated, or AI-generated media straight into the verification flow. To the system, the result looks like a real live capture, and traditional liveness checks aren't built to catch it. "Our customers are facing more sophisticated deepfakes, f
Picsart Opens the AI Behind Its Platform to Developers & Businesses20.11.2026 20:54:00 CET | Press Release
Picsart, the AI media production and distribution platform backed by Sequoia Capital and SoftBank Vision Fund 2, today launched Picsart Platform - a multimodal creative AI hub that gives developers the technology behind the platform used by more than 100 million people each month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120520968/en/ Picsart Opens the AI Behind Its Platform to Developers & Businesses. They can now build their own video, audio, image features using 250+ models from 30+ providers, alongside Picsart's own editing models, through one API, CLI or MCP server. As new video and image models launch every few weeks, managing separate APIs, API keys, and billing systems creates a fragmented ecosystem. By offering unified access to creative tools, Picsart Platform eliminates fragmentation for all creators, spanning independent developers and corporate marketing teams and studios, by providing access to over 25
NetJets Becomes Official Private Aviation Provider of the Hahnenkamm Races in Kitzbühel20.11.2026 18:45:00 CET | Press Release
NetJets, the global leader in private aviation, is delighted to announce its newest partnership with the Hahnenkamm Races in Kitzbühel, Austria, becoming the event's Official Private Aviation Provider. The Hahnenkamm Races are among the most prestigious and celebrated events in world alpine skiing. They attract athletes, business leaders, international guests and winter sports enthusiasts from around the world. Through this partnership, NetJets and the Hahnenkamm Races are aligning two brands renowned for excellence, precision and world-class experiences. The partnership is an exciting addition to NetJets' growing portfolio of premium lifestyle and sporting partnerships, offering Owners unique opportunities to access one of Europe's most iconic winter sporting events. Alongside premium hospitality and unforgettable behind-the-scenes experiences, the collaboration will help create extraordinary moments for Owners, both in the air and on the ground in Kitzbühel. “Kitzbühel is synonymous
Frontgrade Technologies Help Power Critical Computing and Electronics Aboard NASA’s Roman Space Telescope20.11.2026 18:40:00 CET | Press Release
Frontgrade today announced that technologies from across its space electronics portfolio are supporting multiple mission-critical systems aboard NASA’s Nancy Grace Roman Space Telescope, which successfully launched on August 30, 2026. Roman is NASA’s flagship astrophysics observatory designed to investigate dark energy, discover exoplanets and explore the evolution of the universe. Its onboard electronics include radiation-hardened processors and microelectronics, providing critical processing, communications, power-management and control functions across the spacecraft. At the centre of Roman’s computing architecture are Frontgrade Gaisler’s GR740 and GR712RC processors. The GR740 radiation-hardened quad-core LEON4FT processor serves as the computing engine for the Wildcat Processor Card, used in the spacecraft’s primary and redundant Command and Data Handling systems as well as the Instrument Command and Data Handling systems for both the Wide Field Instrument and Coronagraph Instrum
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom